Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.

Turunen AnttiRaija SilvennoinenPartanen AnuJaakko ValtolaTimo SiitonenMervi PutkonenMarja SankeloMarja PyöräläTaru KuittinenKarri PenttiläAnu SikiöEeva-Riitta SavolainenPentti MäntymaaJukka PelkonenVille VarmavuoEsa Jantunen

Published in: Transfusion (2021)

Autograft cellular composition may impact outcome in MM patients after auto-SCT. More studies are needed to define optimal graft composition.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes
cross sectional
multiple myeloma
double blind
anterior cruciate ligament reconstruction